Literature DB >> 10466042

Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats.

L L Melo1, C D Kruel, L M Kliemann, L T Cavazzola, R da L Boeno, P C Silber, R S Grossi.   

Abstract

Studies in human beings and animals have shown that esophageal exposure to duodenal and gastric contents may be important for the development of Barrett's esophagus and its complications, including adenocarcinoma and epidermoid carcinoma. Diethylnitrosamine (DEN) is a carcinogen that stimulates the development of epidermoid carcinoma in the esophagus of mice. The aim of this study was to evaluate the effect of gastroduodenal and gastric content reflux on induction of esophageal carcinogenesis. Gastroesophageal reflux (GER) and gastroduodenoesophageal reflux (GDER) were produced by cardioplasty and esophagoduodenostomy. The chosen carcinogen was DEN, diluted in drinking water, given 3 days a week for 20 consecutive weeks. One hundred Wistar female rats were divided into six groups, as follows: group 1 (18 rats), cardioplasty without DEN; group 2 (18 rats), cardioplasty with DEN; group 3 (10 rats), only water; group 4 (17 rats), cardioplasty with DEN; group 5 (17 rats), esophagoduodenostomy with DEN; group 6 (20 rats), only DEN. GER in isolation induced papillomatosis or ulceration in 22.2% of rats and, when associated with DEN, induced papillomatosis in 61.1% of rats. GDER in isolation induced marked esophagitis in 61.1% of rats, Barrett's esophagus in 16.7% and esophageal adenocarcinoma in 16.7%; when associated with DEN, 23.5% of rats presented marked esophagitis, papillomatosis or ulceration, whereas 76.5% had esophageal carcinoma, with 70.6% epidermoid carcinoma and 5.9% adenocarcinoma. Rats treated with water alone did not show histologic abnormalities of the esophageal mucosa. Rats treated with DEN alone developed papillomas in 50.0% of the cases and remained histologically unchanged in 50.0%. There was no development of low- or high-grade dysplasia in any group. The conclusions are that (1) GDER is significantly more deleterious to esophageal mucosa than GER; (2) in this study, GER did not present carcinogenic potential in relation to the esophagus; (3) GDER in isolation is an esophageal carcinogen, producing Barrett's esophagus and esophageal adenocarcinoma; (4) esophageal oncogenesis caused by GDER is potentiated by DEN, inducing esophageal epidermoid carcinoma; (5) in this study, DEN in isolation did not generate tumors in the esophagus of rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466042     DOI: 10.1046/j.1442-2050.1999.00011.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

Review 1.  Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future.

Authors:  Harit Kapoor; Kush Raj Lohani; Tommy H Lee; Devendra K Agrawal; Sumeet K Mittal
Journal:  Clin Transl Sci       Date:  2015-07-27       Impact factor: 4.689

2.  Endoscopic evaluation of esophago-gastro-jejunostomy in rat model of Barrett's esophagus.

Authors:  S Lu; A W Lowe; G Triadafilopoulos; P-L Hsiung; Y Hao; J M Crawford; T D Wang
Journal:  Dis Esophagus       Date:  2009       Impact factor: 3.429

Review 3.  From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Rui-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

4.  Radiological evaluation of the patency of duodenal-esophageal anastomosis during a long postoperative follow-up: effectiveness of an alkaline reflux model in rats.

Authors:  André Vicente Bigolin; João Vicente Grossi; Juliano Hermes Maeso Montes; Roberto Nicola; Leandro Totti Cavazzola
Journal:  Clin Exp Gastroenterol       Date:  2011-08-23

5.  NF-κB inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.

Authors:  Sotirios G Doukas; Dimitra P Vageli; Clarence T Sasaki
Journal:  J Cell Mol Med       Date:  2018-03-08       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.